INTERACTION OF INTERLEUKIN-2 AND INTERLEUKIN-4 DURING LAK CELL GENERATION

被引：0
|
作者：
INDROVA, M
JANDLOVA, T
BUBENIK, J
机构：
来源：
FOLIA BIOLOGICA | 1992年 / 38卷 / 01期
关键词：
INTERLEUKIN-2; INTERLEUKIN-4; LAK CELLS;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Immunoregulatory lymphokines IL-2 and IL-4 produced by IL-2- and IL-4-cDNA-transformed somatic cells were used for LAK cell generation. The cytolytic effect of LAK cells activated for 3 days with IL-2 and measured by Cr-51 release of three types of target cells, YAC-1 (NK-sensitive), C1498 (NK-resistant) and X63-Ag8.653 (plasmocytoma cell line utilized for insertion of the IL-2 and Il-4 genes), was significantly depressed by adding IL-4 during the activation period.
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [21] DECREASED INTERLEUKIN-2 BETA-CHAIN RECEPTOR EXPRESSION BY INTERLEUKIN-4 ON LGL - INFLUENCE ON THE IL-2 INDUCED CYTOTOXICITY AND PROLIFERATION
    LINDQVIST, C
    OSTMAN, AL
    OKERBLOM, C
    AKERMAN, K
    CANCER LETTERS, 1992, 64 (01) : 43 - 49
  • [22] Opposite effects of interleukin-2 and interleukin-4 on GABA-induced inward currents of dialysed Lymndea neurons
    SRozsa, K
    Rubakhin, SS
    Szucs, A
    Hughes, TK
    Stefano, GB
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 29 (01): : 73 - 77
  • [23] NATURE AND POTENTIAL OF THE REACTIVE RESPONSE TO MOUSE MAMMARY ADENOCARCINOMA CELLS ENGINEERED WITH INTERLEUKIN-2, INTERLEUKIN-4 OR INTERFERON-GAMMA GENES
    MUSIANI, P
    MODESTI, A
    BRUNETTI, M
    MODICA, A
    VITULLO, P
    GULINO, A
    BOSCO, MC
    COLOMBO, MP
    NANNI, P
    CAVALLO, F
    PERICLE, F
    GIOVARELLI, M
    CAVALLO, R
    FORNI, G
    NATURAL IMMUNITY, 1994, 13 (2-3) : 93 - 101
  • [24] Interleukin-4/interleukin-4 receptor gene polymorphisms in hand osteoarthritis
    Vargiolu, M.
    Silvestri, T.
    Bonora, E.
    Dolzani, P.
    Pulsatelli, L.
    Addimanda, O.
    Mancarella, L.
    Punzi, L.
    Fioravanti, A.
    Facchini, A.
    Romeo, G.
    Meliconi, R.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 (06) : 810 - 816
  • [25] Interleukin-4 and interleukin-4 receptor polymorphisms in minimal change nephropathy
    Parry, RG
    Gillespie, KM
    Parnham, A
    Clark, AGB
    Mathieson, PW
    CLINICAL SCIENCE, 1999, 96 (06) : 665 - 668
  • [26] Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13
    McKenzie, ANJ
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (02) : 143 - 151
  • [27] ACTIVATION AND PHENOTYPING OF LAK GENERATED BY EXPOSURE TO PRODUCT OF CELLS TRANSFORMED BY INTERLEUKIN-2 CDNA
    BUBENIK, J
    ZEUTHEN, J
    SIMOVA, J
    JANDLOVA, T
    BUBENIKOVA, D
    RADZIKOWSKI, C
    ANTICANCER RESEARCH, 1992, 12 (03) : 965 - 967
  • [28] HUMAN INTERLEUKIN-4
    BANCHEREAU, J
    DEFRANCE, T
    GALIZZI, JP
    MIOSSEC, P
    ROUSSET, F
    BULLETIN DU CANCER, 1991, 78 (03) : 299 - 306
  • [29] Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy
    Kimura, M
    Tagawa, M
    Takenaga, K
    Kondo, F
    Yamaguchi, T
    Saisho, H
    Nakagawara, A
    Sakiyama, S
    CANCER LETTERS, 1998, 128 (01) : 47 - 53
  • [30] Generation of a variant of human interleukin-4 by alternative splicing
    Alms, WJ
    Atamas, SP
    Yurovsky, VV
    White, B
    MOLECULAR IMMUNOLOGY, 1996, 33 (4-5) : 361 - 370
12345